HeadlineShine

Already jumped 55% in 2026, PL Capital sees more returns in Sai Lifesciences shares | Check target, upside

Mint ·First reported 1d ago

Mint

Image: Mint

PL Capital believes the company is well positioned to benefit from increasing pharmaceutical outsourcing, a deep commercial pipeline and capacity expansion

Summary from Mint

Read the full story on Mint

Follow

React

More on PL Capital

BusinessNDTV Profit·1d ago

Nippon Q2 Review: PL Capital Lowers Target Price But Sees 23% Upside; Here's Why

Business2 sources·1d ago

KEI Industries Q2 Review: PL Capital Stays Bullish On Healthy Growth Outlook; Check Target Price

More business

Hindustan Times

Business5 sources·1h ago

Defence secretary Rajesh Kumar Singh gets one-year extension

Business7 sources·3h ago

Rahul Gandhi's November 1 Rally: Delhi Traders Fear Rs 10,000 Crore Business Impact

Business5 sources·5h ago

JDU expels Mokama MLA Anant Singh from party for 6 years over controversial remarks

Business7 sources·12h ago

Gangster Himanshu Bhau, Wanted In India For Multiple Murders, Arrested In US

Business4 sources·3h ago

BJP alleges Sanjay Raut faked AI audio on ₹500 crore payout to Jarange; Sena UBT leader claims BJP MLC leaked clip

Business6 sources·1h ago

7 Killed, 34 Injured As Gunmen Open Fire In Jordan Church During Funeral

Top stories in India

Sports6 sources·6h ago

Mumbai Indians appoint Kieron Pollard as head coach ahead of IPL 2027

Sports4 sources·2h ago

Manchester City's perfect Premier League start ends with defeat to Aston Villa

Hindustan Times

2 sources·1h ago

Same Name Appears 10 Times On Voter Roll. 5 UP Poll Officials Get Notices

Business2 sources·1h ago

Saudi issues 'potential danger' warning for Mecca

Hindustan Times

5 sources·2h ago

Jaishankar in Baku: Can trade and connectivity help Azerbaijan reset ties with India after Operation Sindoor fallout?

Business2 sources·1h ago

Probe Agency ED Moves Top Court Against Quashing Of NewsClick Case